Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait

Objective Subsequent protection from SARS-CoV-2 infection in paediatrics is not well reported in the literature. We aimed to describe the clinical characteristics and dynamics of SARS-CoV-2 PCR repositivity in children.Design This is a population-level retrospective cohort study.Setting Patients wer...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Alghounaim, Saadoun Bin-Hasan, Fatemah Alhaddad, Ali Abdulkareem, Danah Alsharrah, Abdullah Alkandari, Mona Al-Ahmad, Hashem Al Hashemi
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/6/e056371.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832574355745275904
author Mohammad Alghounaim
Saadoun Bin-Hasan
Fatemah Alhaddad
Ali Abdulkareem
Danah Alsharrah
Abdullah Alkandari
Mona Al-Ahmad
Hashem Al Hashemi
author_facet Mohammad Alghounaim
Saadoun Bin-Hasan
Fatemah Alhaddad
Ali Abdulkareem
Danah Alsharrah
Abdullah Alkandari
Mona Al-Ahmad
Hashem Al Hashemi
author_sort Mohammad Alghounaim
collection DOAJ
description Objective Subsequent protection from SARS-CoV-2 infection in paediatrics is not well reported in the literature. We aimed to describe the clinical characteristics and dynamics of SARS-CoV-2 PCR repositivity in children.Design This is a population-level retrospective cohort study.Setting Patients were identified through multiple national-level electronic COVID-19 databases that cover all primary, secondary and tertiary centres in Kuwait.Participants The study included children 12 years and younger between 28 February 2020 and 6 March 2021. SARS-CoV-2 reinfection was defined as having two or more positive SARS-CoV-2 PCR tests done on a respiratory sample, at least 45 days apart. Clinical data were obtained from the Pediatric COVID-19 Registry in Kuwait.Primary and secondary outcome measures The primary measure is to estimate SARS-CoV-2 PCR repositivity rate. The secondary objective was to establish average duration between first and subsequent SARS-CoV-2 infection. Descriptive statistics were used to present clinical data for each infection episode. Also, incidence-sensitivity analysis was performed to evaluate 60-day and 90-day PCR repositivity intervals.Results Thirty paediatric patients with COVID-19 had SARS-CoV-2 reinfection at an incidence of 1.02 (95% CI 0.71 to 1.45) infection per 100 000 person-days and a median time to reinfection of 83 (IQR 62–128.75) days. The incidence of reinfection decreased to 0.78 (95% CI 0.52 to 1.17) and 0.47 (95% CI 0.28 to 0.79) per person-day when the minimum interval between PCR repositivity was increased to 60 and 90 days, respectively. The mean age of reinfected subjects was 8.5 (IQR 3.7–10.3) years and the majority (70%) were girls. Most children (55.2%) had asymptomatic reinfection. Fever was the most common presentation in symptomatic patients. One immunocompromised experienced two reinfection episodes.Conclusion SARS-CoV-2 reinfection is uncommon in children. Previous confirmed COVID-19 in children seems to result in a milder reinfection.
format Article
id doaj-art-207c4c3920184a9bb89965d548cd8d8d
institution Kabale University
issn 2044-6055
language English
publishDate 2022-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-207c4c3920184a9bb89965d548cd8d8d2025-02-01T13:35:14ZengBMJ Publishing GroupBMJ Open2044-60552022-06-0112610.1136/bmjopen-2021-056371Incidence of SARS-CoV-2 reinfection in a paediatric cohort in KuwaitMohammad Alghounaim0Saadoun Bin-Hasan1Fatemah Alhaddad2Ali Abdulkareem3Danah Alsharrah4Abdullah Alkandari5Mona Al-Ahmad6Hashem Al Hashemi7Department of Pediatrics, Amiri Hospital, Kuwait City, KuwaitDepartment of Pediatrics, Farwaniya Hospital, Farwaniya, KuwaitDepartment of Pediatrics, Farwaniya Hospital, Farwaniya, KuwaitDepartment of Pediatrics, Farwaniya Hospital, Farwaniya, KuwaitDepartment of Pediatrics, Farwaniya Hospital, Farwaniya, KuwaitPopulation Health Department, Dasman Diabetes Institute, Kuwait City, KuwaitDepartment of Microbiology, Kuwait University Faculty of Medicine, Safat, Al Asimah, KuwaitDepartment of Pediatrics, Farwaniya Hospital, Farwaniya, KuwaitObjective Subsequent protection from SARS-CoV-2 infection in paediatrics is not well reported in the literature. We aimed to describe the clinical characteristics and dynamics of SARS-CoV-2 PCR repositivity in children.Design This is a population-level retrospective cohort study.Setting Patients were identified through multiple national-level electronic COVID-19 databases that cover all primary, secondary and tertiary centres in Kuwait.Participants The study included children 12 years and younger between 28 February 2020 and 6 March 2021. SARS-CoV-2 reinfection was defined as having two or more positive SARS-CoV-2 PCR tests done on a respiratory sample, at least 45 days apart. Clinical data were obtained from the Pediatric COVID-19 Registry in Kuwait.Primary and secondary outcome measures The primary measure is to estimate SARS-CoV-2 PCR repositivity rate. The secondary objective was to establish average duration between first and subsequent SARS-CoV-2 infection. Descriptive statistics were used to present clinical data for each infection episode. Also, incidence-sensitivity analysis was performed to evaluate 60-day and 90-day PCR repositivity intervals.Results Thirty paediatric patients with COVID-19 had SARS-CoV-2 reinfection at an incidence of 1.02 (95% CI 0.71 to 1.45) infection per 100 000 person-days and a median time to reinfection of 83 (IQR 62–128.75) days. The incidence of reinfection decreased to 0.78 (95% CI 0.52 to 1.17) and 0.47 (95% CI 0.28 to 0.79) per person-day when the minimum interval between PCR repositivity was increased to 60 and 90 days, respectively. The mean age of reinfected subjects was 8.5 (IQR 3.7–10.3) years and the majority (70%) were girls. Most children (55.2%) had asymptomatic reinfection. Fever was the most common presentation in symptomatic patients. One immunocompromised experienced two reinfection episodes.Conclusion SARS-CoV-2 reinfection is uncommon in children. Previous confirmed COVID-19 in children seems to result in a milder reinfection.https://bmjopen.bmj.com/content/12/6/e056371.full
spellingShingle Mohammad Alghounaim
Saadoun Bin-Hasan
Fatemah Alhaddad
Ali Abdulkareem
Danah Alsharrah
Abdullah Alkandari
Mona Al-Ahmad
Hashem Al Hashemi
Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
BMJ Open
title Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
title_full Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
title_fullStr Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
title_full_unstemmed Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
title_short Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait
title_sort incidence of sars cov 2 reinfection in a paediatric cohort in kuwait
url https://bmjopen.bmj.com/content/12/6/e056371.full
work_keys_str_mv AT mohammadalghounaim incidenceofsarscov2reinfectioninapaediatriccohortinkuwait
AT saadounbinhasan incidenceofsarscov2reinfectioninapaediatriccohortinkuwait
AT fatemahalhaddad incidenceofsarscov2reinfectioninapaediatriccohortinkuwait
AT aliabdulkareem incidenceofsarscov2reinfectioninapaediatriccohortinkuwait
AT danahalsharrah incidenceofsarscov2reinfectioninapaediatriccohortinkuwait
AT abdullahalkandari incidenceofsarscov2reinfectioninapaediatriccohortinkuwait
AT monaalahmad incidenceofsarscov2reinfectioninapaediatriccohortinkuwait
AT hashemalhashemi incidenceofsarscov2reinfectioninapaediatriccohortinkuwait